Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Interferon gamma Potential treatment - pre-clinical evidence Natural product Antiviral Feb/05/2021 1 1
Interferon beta-1b Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 3 2
Interferon lambda-1 Potential treatment - pre-clinical evidence Natural product Antiviral Sep/10/2020 1 0
sdAb 1E2 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020 1 0
sdAb 4D8 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020 1 0
sdAb 3F11 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020 1 0
sdAb 5F8 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020 1 0
sdAb 2F2 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/10/2020 1 0